YGION Biomedical

Recent Finacing

Series A

Recent Raise

$16.2M

Ygion Biomedical develops individualized neoantigen peptide cancer vaccines using sequencing and bioinformatics integrated with its CARGONAUT vaccine platform to identify, produce, and deliver tumor-specific neoepitopes; lead YG-01 is preclinical.